Eli Lilly, the maker of the popular weight loss drug Zepbound, revealed what Bloomberg called a "shocking first miss" during its most recent quarterly sales. Shares plummeted by almost eight percent on Wednesday with Zepbound and diabetes drug Mounjaro, missing Wall Street estimates by almost $900 million in sales. That's despite the astronomical rise in […]

---

Link :
https://futurism.com/neoscope/eli-lilly-major-problem-weight-loss-drugs